Mark J. Vignola's Insider Trades & SAST Disclosures
Mark J. Vignola's most recent trade in Terns Pharmaceuticals Inc was a trade of 9,059 Common Stock done at an average price of $5.8 . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark J. Vignola.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 02 Jan 2025 | 9,059 | 74,752 | - | 5.8 | 52,500 | Common Stock | |
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 02 Jan 2025 | 8,129 | 83,811 | - | 5.7 | 46,524 | Common Stock | |
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 10 Sep 2024 | 10,000 | 55,000 | - | - | Stock Option (Right to Buy) | ||
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 10 Sep 2024 | 10,000 | 91,940 | - | 11 | 110,000 | Common Stock | |
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 10 Sep 2024 | 10,000 | 101,940 | - | 5.4 | 53,600 | Common Stock | |
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 31 May 2024 | 4,791 | 91,940 | - | 4.4 | 21,272 | Common Stock | |
| Terns Pharmaceuticals Inc | Vignola Mark J. | Chief Financial Officer | 23 Jan 2024 | 137,500 | 137,500 | - | - | Stock Option (Right to Buy) | ||
| Terns Pharmaceuticals Inc | J. Vignola Mark | Chief Financial Officer | 23 Jan 2024 | 68,750 | 87,149 | - | 0 | Common Stock | ||
| Terns Pharmaceuticals Inc | Vignola J. Mark | Chief Financial Officer | 30 Nov 2023 | 743 | 18,399 | - | 3.8 | 2,809 | Common Stock | |
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 01 Feb 2023 | 360,000 | 360,000 | - | - | Stock Option (Right to Buy) | ||
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 01 Feb 2023 | 3 | 7,659 | - | 1.3 | 4 | Common Stock | |
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 31 May 2022 | 7,656 | 7,656 | - | 1.5 | 11,254 | Common Stock | |
| Terns Pharmaceuticals Inc | Mark J. Vignola | Chief Financial Officer | 28 Sep 2021 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges